BRCA1 pathogenic variants in women with premature ovarian failure
- Авторлар: Rshtuni S.D.1, Chernukha G.E.1, Bystritskiy A.A.1, Tabeeva G.I.1, Krasheninnikova R.V.1, Marchenko L.A.1
-
Мекемелер:
- Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Шығарылым: № 10 (2022)
- Беттер: 76-82
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249533
- DOI: https://doi.org/10.18565/aig.2022.10.76-82
- ID: 249533
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Sandra Rshtuni
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: rshtunisandra@gmail.com
postgraduate student, Department of Endocrinological Gynecology
Galina Chernukha
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_chemukha@oparina4.ru
Dr. Med. Sci., Professor, Department of Endocrinological Gynecology
Andrey Bystritskiy
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_bystritskiy@opanna4.ru
Leading researcher at the Laboratory of Molecular Genetic Methods, Institute of Reproductive Genetics
Gyuzyal Tabeeva
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: doctor.gtab@gmail.com
Senior Researcher at the Department of Gynecological Endocrinology
Regina Krasheninnikova
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: krv82@yandex.ru
molecilar genetic lab pathologist
Larisa Marchenko
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: l_marchenko@yandex.ru
Dr. Med. Sci., Professor, Department of Endocrinological Gynecology
Әдебиет тізімі
- Российское общество акушеров-гинекологов. Менопауза и климактерическое состояние у женщины. Клинические рекомендации. М.; 2021. 86 c.
- Табеева Г.И., Позднякова А.А., Марченко Л.А. Эволюция диагностических и лечебных подходов при преждевременной недостаточности яичников. Акушерство и гинекология: новости, мнения, обучение. 2013; 2(2): 31-6.
- Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem.Cell. 2012; 10(6): 678-84. https://dx.doi.org/10.1016/j.stem.2012.05.005.
- Martens U.M., Chavez E.A., Poon S.S., Schmoor C., Lansdorp P.M. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp. Cell Res. 2000; 256(1): 291-9. https://dx.doi.org/10.1006/excr.2000.4823.
- Bakkenist C.J., Kastan M.B. Initiating cellular stress responses. Cell. 2004; 118(1): 9-17. https://dx.doi.org/10.1016/j.cell.2004.06.023.
- Faddy M.J., Gosden R.G., Gougeon A., Richardson S.J., Nelson J.F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 1992; 7(10): 1342-6. https://dx.doi.org/10.1093/oxfordjournals.humrep.a137570.
- Franga M.M., Mendonca B.B. Genetics of ovarian insufficiency and defects of folliculogenesis. Best Pract. Res. Clin. Endocrinol. Metab. 2022; 36(1): 101594. https://dx.doi.org/10.1016/j.beem.2021.101594.
- Wang E.T., Pisarska M.D., Bresee C., Chen Y.D., Lester J., Afshar Y. et al. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil. Steril. 2014; 102(6): 1723-8. https://dx.doi.org/10.1016/j.fertnstert.2014.08.014.
- Finch A., Valentini A., Greenblatt E., Lynch H.T., Ghadirian P., Armel S. et al.; Hereditary Breast Cancer Study Group. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation. Fertil. Steril. 2013; 99(6): 1724-8. https://dx.doi.org/10.1016/j.fertnstert.2013.01.109.
- Titus S., Li F., Stobezki R., Akula K., Unsal E., Jeong K. et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci. Transl. Med. 2013; 5(172): 172ra21. https://dx.doi.org/10.1126/scitranslmed.3004925.
- Ford D., Easton D.F., Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet. 1995; 57(6): 1457-62.
- Oktay K., Kim J.Y., Barad D., Babayev S.N. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J. Clin. Oncol. 2010; 28(2): 240-4. https://dx.doi.org/10.1200/JCO.2009.24.2057.
- Webber L., Davies M., Anderson R., Bartlett J., Braat D., Cartwright B. et al.; European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum. Reprod. 2016; 31(5): 926-37. https://dx.doi.org/10.1093/humrep/dew027.
- Nykamp K., Anderson M., Powers M., Garcia J., Herrera B., Ho Y.Y. et al.; Invitae Clinical Genomics Group; Topper S. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet. Med. 2017; 19(10): 1105-17. https://dx.doi.org/10.1038/gim.2017.37.
- Hu C., Hart S.N., Gnanaolivu R., Huang H., Lee K.Y., Na J. et al. A population-based study of genes previously implicated in breast cancer. N. Engl. J. Med. 2021; 384(5): 440-51. https://dx.doi.org/10.1056/NEJMoa2005936.
- Malander S., Ridderheim M., Masback A., Loman N., Kristoffersson U., Olsson H. et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur. J. Cancer. 2004; 40(3): 422-8. https://dx.doi.org/10.1016Zj.ejca.2003.09.016.
- Грудинина Н.А., Голубков В.И., Тихомирова О.С., Брежнева Т.В., Хансон К.П., Васильев В.Б., Мандельштам М.Ю. Преобладание широко распространенных мутаций в гене BRCA1 у больных семейными формами рака молочной железы Санкт-Петербурга. Генетика. 2005; 41(3): 405-10.
- Turan V., Oktay K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum. Reprod. Update. 2020; 26(1): 43-57. https://dx.doi.org/10.1093/humupd/dmz043.
- Phillips K.A., Collins I.M., Milne R.L., McLachlan S.A., Friedlander M., Hickey M. et al. Anti-Mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Hum. Reprod. 2016; 31(5): 1126-32. https://dx.doi.org/10.1093/humrep/dew044.
- Giordano S., Garrett-Mayer E., Mittal N., Smith K., Shulman L., Passaglia C. et al. Association of BRCA1 mutations with impaired ovarian reserve: connection between infertility and breast/ovarian cancer risk. J. Adolesc. Young Adult Oncol. 2016; 5(4): 337-43. https://dx.doi.ois/10.1089/jayao.2016.0009.
- Ben-Aharon I., Levi M., Margel D., Yerushalmi R., Rizel S., Perry S. et al. Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging? Oncotarget. 2018; 9(22): 15931-41. https://dx.doi.org/10.18632/oncotarget.24638.